↓ Skip to main content

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Overview of attention for article published in Clinical Cancer Research, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
2 X users
patent
16 patents
facebook
1 Facebook page
f1000
1 research highlight platform

Readers on

mendeley
321 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Published in
Clinical Cancer Research, June 2013
DOI 10.1158/1078-0432.ccr-13-0525
Pubmed ID
Authors
Abstract

To determine the role of the CCL2/CCR2 axis and inflammatory monocytes (CCR2(+)/CD14(+)) as immunotherapeutic targets in the treatment of pancreatic cancer.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 321 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
United States 5 2%
Netherlands 1 <1%
Japan 1 <1%
United Kingdom 1 <1%
Unknown 313 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 67 21%
Researcher 50 16%
Student > Master 31 10%
Student > Bachelor 29 9%
Student > Doctoral Student 25 8%
Other 43 13%
Unknown 76 24%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 63 20%
Biochemistry, Genetics and Molecular Biology 56 17%
Agricultural and Biological Sciences 39 12%
Immunology and Microbiology 34 11%
Pharmacology, Toxicology and Pharmaceutical Science 13 4%
Other 31 10%
Unknown 85 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2026.
All research outputs
#2,728,245
of 23,419,482 outputs
Outputs from Clinical Cancer Research
#2,403
of 12,731 outputs
Outputs of similar age
#23,664
of 196,029 outputs
Outputs of similar age from Clinical Cancer Research
#26
of 187 outputs
Altmetric has tracked 23,419,482 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,731 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,029 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 187 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.